Dxige Research Inc., Northwestern University - Department of Urology, Northwestern University - Department of Urology, Northwestern University - Department of Urology, Northwestern University - Department of Urology, Northwestern University - Department of Urology, Federal University of Parana (UFPR) - Bioinformatics and Systems Biology Laboratory, French League Against Cancer - Tumor Identity Cards Program, French League Against Cancer - Tumor Identity Cards Program, ImmunoMind Inc., ImmunoMind Inc., Northwestern University - Department of Pathology, Università Vita-Salute San Raffaele - Department of Medical Oncology, Oncology Institute of Southern Switzerland - Service of Medical Oncology, Università Vita-Salute San RaffaeleUniversità Vita-Salute San Raffaele - Department of Urology, Queen Mary University of London - Centre for Experimental Cancer Medicine, Università Vita-Salute San Raffaele - Department of Medical Oncology and Northwestern University, Feinberg School of Medicine - Departments of Urology, and Biochemistry and Molecular GeneticsNorthwestern University - Department of Urology

French League Against Cancer - Tumor Identity Cards Program, French League Against Cancer - Tumor Identity Cards Program, Institut Curie Hospital Group - Department of Pathology, Lund University - Division of Urological Research, Canada's Michael Smith Genome Sciences Center, University of Bern - Department of Urology, University of North Carolina (UNC) at Chapel Hill - Department of Genetics, Memorial Sloan Kettering Cancer Center - Department of Pathology, Johns Hopkins University - Greenberg Bladder Cancer Institute, Federal University of Parana (UFPR) - Bioinformatics and Systems Biology Laboratory, Federal University of Parana (UFPR) - Bioinformatics and Systems Biology Laboratory, Institut Curie Hospital Group - Department of Pathology, Lund University - Division of Oncology and Pathology, Baylor University - Department of Medicine, University of North Carolina (UNC) at Chapel Hill - Department of Genetics, University of Toronto - Division of Urology, Friedrich-Alexander-Universität Erlangen-Nürnberg, University of Texas at Houston - Department of Urology, Harvard Medical School - Bladder Cancer Center, Queen Mary University of London - Centre for Experimental Cancer Medicine, Spanish National Cancer Research Centre (CNIO) - Genetic and Molecular Epidemiology Group, Baylor University - Department of Molecular and Cellular Biology, University of North Carolina (UNC) at Chapel Hill - Department of Genetics, Johns Hopkins University - Greenberg Bladder Cancer Institute, University of British Columbia (UBC) - Department of Urologic Sciences, Aarhus University Hospital - Department of Molecular Medicine, Lund University - Division of Oncology and Pathology, Baylor University - Scott Department of Urology, Spanish National Cancer Research Centre (CNIO) - Epithelial Carcinogenesis Group, Institut Curie - Molecular Oncology and Independent